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Blood Pressures and lndxes of Anglogenesis, Endothelial Dysfunction and lluombogenesis 
Healthy Controls Hypertensive Patients p Value 
Systolic BP (mmHg) 134+ 11 161 * 21 <O.OOl 
Diastolic BP 81 *7 95 * 16 0.002 
(mmHg) 
FMD (X) 11.9kll.6 3.9 * 5.8 0.002 
vWf (IU/dl) 111.6 * 32.9 103.7 * 27.1 0.330 
VEGF @g/ml) 96 [60-l 301 105 [53-l 2801 0.358 
sFll-1 @g/ml) 1.3 [0.5-2.61 1.5 [0.5-l 111 0.217 
Tie-2 @g/ml) 4.4 [2.7-6.31 7.25 [3.5-37.51 0.043 
TF @@ml) 15 [Il.161 19 [13-321 0.023 
Values expressed es meanistandard deviation or median [interquartile range] and 
analysed by Unpaired T Test or Mann Whitney es appropriate 
lowest quinttle of normal FG. This finding suggests that improving glycemic control may 
mitigate the proinflammatory state in subjects with diabetes and insulin resistance. 
5:15 p.m. Fasting dwosecdagory 
832-6 Long-Term Follow-Up of Hypertensive Patients With 
Angiographically Normal Coronary Arteries: Prognostic 
Value of Epicardial Coronary Endothelial Dysfunction 
Alain Nitenberq, Denis Chemla, lsabelle Antony, CHU Jean Verdier, Bondy, France, 
CHU Bic&re, Le Kremlin-BicBtre, France 
Background: epicardial coronary endothelial dysfunction independently predicts cardio- 
vascular events in patients with coronary risk factors and without coronary atherosclero- 
sis. This study was designed to evaluate outcome of hypertensive patients (HP) on the 
basis of their epicardial coronary endothelial function. 
Methods: 68 control subjects (CS), 53 males, 15 females (46.6i7.6 years) and 63 HP, 54 
males, 29 females (51.3i7.9 years) with angiographically normal coronary arteries and 
without any other coronary risk factor underwent epicardial coronary reactivity assess- 
ment to cold pressor test (CPT) using quantitative coronary angiography. Unpredictable 
cardiovascular events (CVE) (sudden cardiac death, stable and unstable angina, myo- 
cardial Infarction, stroke, angioplasty, coronary artery surgery) were recorded with a 
mean follow-up of 115 months (range 64.132). 
Results: in CS, dilation occurred in &X2%, no change in 11.8% (mean diameter change: 
+14.6t9.3%) and there was no constriction. In HP, coronary artery dilation occurred in 
13.3%, no change in 25.3% (mean diameter change: +10.9+11.2%). and constriction in 
61.4% (mean diameter change: -12.7+3.4%). Endothelium-independent dilation to 
nitrates was normal in the 2 arouos /26.7+12.6% and 25.&l 1.9%. respectivelv. NS). In _ . 
CS, there was 3 CVE in 2 subjects (2.9%). In HP, there was 17 CVE III 12 patients 
(14.5%. o<O.Ol vs CSI. and in this orouo there was 15 CVE in the lo/51 oatients H9.6%) 
. I  
, .  ” I  
with coronary artery constriction, and 2 CVE in the 2/33 patients (6.3%) with no change 
or dilation (p<O.O5). 
Conclusion: in hypertensive patients with angiographically normal coronary arteries and 
without other coronary risk factors, epicardial coronary endothelial dysfunction assessed 
by a simple cold pressor test is predictive of long-term cardiovascular events. 
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840-1 Relation Between Fasting Glucose and C-Reactive 
Protein in Middle-Aged Subjects 
Doron Aronson Peter Bartha, Oren Zlnder, Arthur Kerner, Ella Shitman, Gerald J. Brook, 
Yishai Levi, Rambam. Haifa, Israel 
Introduction: Elevation of C-reactive protein (CRP) is associated with components of 
the metabolic syndrome, and especially with measures of obesity. Hyperglycemia can 
stimulate release of cytokines from venous cell types including adipocytes. However, the 
relation between glycemic status and CRP is not known. Methods: We studied the rela- 
tion of high-sensitivity CRP to fasting glucose (FG) and components of the metabolic 
syndrome in a population-based cross secbonal study (n = 1000; age, 50 + 9 years). 
Results: CRP increased continuously from the lowest quartile of normal FG to impaired 
FG and to diabetes (Figure). Increasing CRP with higher FG levels was apparent even 
among subjects with FG in the normal range (P = 0.039 for trend). Subjects with FG in 
the upper quartile of normal FG had higher CRP compared to subjects in the lower quar- 
tile (P= 0.035). There was a positive crude correlation between CRP and smoking, post- 
menopausal hormone use, body mass index, FG. triglycerides, hypertension, and uric 
acid (P= 0.002 to O.OOOl), and a negative correlation with HDL (PC 0.0001) and physi- 
cal activity (P = 0.002). After adjustment for potential confounders in a stepwise multivari- 
ate linear regression, FG remained independently related to CRP (P= 0.019). 
Conclusion: CRP increases continuously across the spectrum of FG, beginning in the 
8:45 a.m. 
840-2 Age Dependent Association Between High Sensitivity 
C-Reactive Protein and Tumor Necrosis Factor 
Functional Variants 
Fernando Aratiio, Alexandre C. Pereira, Gloria F. Motta, Daniela L. Jardim, Jose E. 
Krieger, Alfred0 J. Mansur, Heart Institute - InCor, SBo Paula, Brazil 
High sensitivity C-Reactive protein (hs-CRP) is a promising biochemical marker for pre- 
diction of coronary events. Genetic factors may influence hs-CRP concentration. We 
hypothesized that a genetic variant at position-306 in the promoter region of the TNF 
alpha gene (TNFA2 allele), which is related to increased circulating levels of TNF, may 
be associated with higher hs-CRP in a Brazilian population. This study enrolled 664 
healthy adults volunteers, 295 men (43. 1%) and 369 women (57. l%), designed to 
quantify environmental and genetic variables associated with serum hs-CRP. Ethnic dis- 
tribution was concordant with the ethnic distribution in the country. TNF -306 genotype 
was obtained through PCR amplification and restriction enzyme digestion in DNA from 
peripheral leucocytes. TNFA Alleles were in Hardy-Weinberg equilibrium in this sample. 
Ethnic&y was the single demographic variable with different distribution regarding harbor- 
ing or not the TNFAP allele (p=O.O3). There was no statistically significant difference 
between the individuals with or without the TNFAP allele and hs-CRP serum concentra- 
tion. However, there was a tendency for higher hs-CRP serum levels in the TNFA2 group 
and a higher frequency of Individuals with the TNFAP allele in hs-CRP quartile 4. 
Through ANOVA factorial modeling using log transformed hs-CRP serum level as the 
dependent variable a significant association between hs-CRP and the presence of 
TNFAP allele was discloused after stratifying our analysis for age quartiles (p= 0.01). 
TNFA genotype was significantly associated with hs-CRP serum levels in the fourth 
quartile of age (geometric mean serum level in this quartile 0.096 (0.02) for TNFA11 
TNFAl individuals and 0.196 (0.051) for individuals harbonng the TNFAP allele). This 
association remained statistically significant after adjustmet for ethnicity (p = 0.03). 
Finally, the presence of TNFAP allele in this age group increased the odds of being in the 
fourth quartile of hs-CRP concentration (p value = 0.04, OR = 5.1, 95% Cl = 1.1 
24.9).These data are consistent with an association between a functional genetic variant 
of the TNF alpha gene and hs-CRP levels at particular age groups 
9:00 a.m. 
840-3 Matrix Metalloproteinases and Their Inhibitors in 
Premature Coronary Atherosclerosis: Relation With 
Inflammation and Metabolic Markers 
Samuele Nanni, Giovanni Melandri. Roeland Hanemaaijer, Vittorio Cervi, Luciana 
Tom&, Chiara Melloni, Pierluigi Tricoci, Angelo Branzi, Institute of Cardiology, Bologna, 
Italy. T.N.O.-PG, Leiden, The Netherlands 
Background: little is known on determinants of matrix metalloproteinases (MMPs) plasma 
concentration and activity in coronary artery disease (CAD). 
Methods: we studied 80 male patients (pts) with premature (5 55 years) CAD (either 
myocardial infarction or angina with angiographic evidence of CAD) and 40 healthy male 
controls of similar age. The pts were subdivided into three groups as follows: 1) 20 con- 
secutive pts with ST elevation acute myocardial infarction (STEMI), 2) 29 consecutive pts 
with unstable angina (UA) or non-STEM1 (UAINSTEMI), 3) 31 consecutive pts with stable 
CAD. 
MMP-2 (i.e gelatinase A) and MMP-9 (i.e. gelatinase B) plasma total activities were mea- 
sured along with concentrations of MMP-2, MMP-3 (i.e. stromelysin-1), MMP-9 and spe- 
cific tissue inhibitors of MMPs. such as TIMP-1 and TIMP-2. Inflammation and metabolic 
markers were also evaluated. 
Results: MMPs and TlMPs data are deplcted in table 1. MMP-2 total activity was lower 
both in the whole pts population and in ACS pts compared to controls (both p < 0.002). 
MMP-2 total activity inversely correlated with haptoglobin and blood glucose ( p 0.032). 
TIMP-1 strongly correlated with blood glucose and both C-reactive protein and haptoglo- 
bin (all psO.005). 
Conclusion: 
in patients with premature CAD MMP-9 and TIMP-1 concentrations are increased, while 
TIMP-2 concentration and MMP-2 total activity are decreased. TIMP-1 and MMP-2 total 
activity strongly correlated with inflammation markers and with blood glucose levels. 
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Table I 
STEMI UAINSTEMI STABLECAD CONTROLS P 
[MMP-P] (mcg/ml)) 554.9+164.3 502.4k170.0 584&215.4 494.0*178.3 0.160 
MMP-2 ACTlVll-Y 33.0+21.5 33.9r14.9 35.7*15.5 42.4el4.6 0.073 
(absorbance units) 
[MMP-31 (mcg/ml) 33.6*15.7 25.0*9.0 28.0*13.6 29.6zt12.5 0.130 
[MMP-91 (mcg/ml) 192.4+123.9 141.5+105.2 82.9+50.1 114.3i74.9 <0.001 
MMP-9 ACTIVITY 34.8*21.2 30.5*17.7 24.6~10.4 29.5*1&S 0.222 
(absorbance units) 
[TIMP-1] (mcg/ml) 279.9A72.0 277.5r50.0 298.6e43.0 25O.Oi49.5 0.002 
[TIMP-21 (mcgiml) 25.3kll.9 26.2kl3.1 23.3k7.2 38.9+12.3 <O.col 
9:15 a.m. 
840-4 Lipoprotein-Associated Phospholipase A2 is 
Associated With Angiographic Coronary Artery Disease 
on Univariate Analysis but Loses Independent 
Predictive Value in a Multivariate Model 
Emmanouil S. Brilakls, Joseph P. McConnell, Ryan J. Lennon. Jeffrey G. Meyer, Peter B. 
Berger, Mayo Clinic, Rochester, MN 
Background: Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been recently 
implicated in the parhogenesis of atherosclerosis Lp-PLAP has been correlated with 
angiographic coronary artery disesase (CAD) in only one study (n=148). In that study, 
Lp-PLAP levels were higher in pabents (pts) with CAD than controls, but coronary 
angiography was not performed in all of the pts or controls. 
Methods: We analyzed the associabon between Lp-PLAP level and CAD in 504 consec- 
utive pt.s undergang clinically indicated coronary angiography between 7198 and 1199. 
Lp-PLAP levels were measured using an enzyme-linked immunoassay (diaDexus, Inc, 
South San Francisco, Callfornv.). 
Results: Mean age was 6Oill years; 38% were women; 24% had normal coronary 
arteries (~10% stenoses); 22% had stenoses 10.50%; and 17%. 16%, and 21% had sin- 
gle, double, and triple vessel disease (>50% ?&noses), respectively. Overall, mean (t 
SD) Lp-PLAP (ng/mL) was 244 * 92. Mean Lp-PLA2 was higher I” pts with significant 
CAD, defined as >50% luminal stenosis (252 f. 97 vs. 235 * 83, p=O.O34). Mean (+ SD) 
Lp-PLAP in pts with ~10% luminal stenosis. IO%-50% luminal stenosis, and significant 1. 
/ 2-, and 3- vessel CAD were 222 f 85, 248 f 80, 242 f 74, 250 * 96, and 262 * 114, 
respectively (p=O.O2). Mean (* SD) Lp-PLAP levels in pts with acute myocardial infarc- 
tion (n=33), unstable angina (n=l25), or no acute coronary syndromes (n=346) were 252 
f 77, 244 * 83, and 244 f 96, respectively (p=O.t38). Lp-PLAP levels correlated with gen- 
der, current smoking, hypertension, total cholesterol, triglycerides. LDL and HDL choles- 
terol, but not with age. However, after adjusting for these clinical and lipid variables, Lp- 
PLA2 was no longer independently predictive of anglographic CAD (p=O.63). 
Conclusion: Lp-PLA2 levels were higher in patients with angiographic CAD. However, 
the predictive value was not Independent of traditional CAD risk factors in this study. The 
association between Lp-PlA2 and outcomes I” this population is currently under mvesti- 
gation. 
9:30 a.m. 
840-5 Plasma C-Reactive Protein Is Not Elevated in Physically 
Active Postmenopausal Women Taking Hormone 
Replacement Therapy 
Brian L. Stauffer, Derek T. Smith, Greta L. Hoetzer, Jared J. Greiner, Christopher A. 
DeSouza, University of Colorado Health Sciences Center, Denver, CO, University of 
Colorado at Boulder, Boulder, CO 
Background: C-reactive protein (CRP) is a strong independent predIctor of future car- 
diovascular events. Hormone replacement therapy (HRT) increases plasma CRP con- 
centrations in postmenopausal women. In contrast, habitual physical activity lowers 
plasma CRP levels. Currently there are no data regarding the influence of regular physl- 
cal activity on the adverse effect of HRT use on CRP. We hypothesized that HRT-related 
increases in CAP would either be blunted or absent in postmenopausal women who reg- 
ularly perform endurance exercise. 
Methods: Using a cross-sectional study design, plasma CRP and interleukln-6 levels 
were measured in sedentary and physically active (PA) postmenopausal women who 
were either taking or not taking HRT. 
Results: Plasma CRP levels were -75% higher in the sedentary users versus nonusers 
of HRT (1.9+0.3 vs. l.liO.2 mg/L; p &It; 0.01). However, there was no significant differ- 
ence in CRP levels between the PA users and nonusers of HRT (0.6*0.1 vs. 0.4&l mg/ 
L). Plasma CRP concentrations were -65% lower in PA us?rs and nonusers of HRT than 
their respective sedentary counterparts. There was no significant influence of HRT use 
on plasma interleukin-6 concentrations I” either the sedentary or PA active women. Only 
the PA women not taking HRT demonstrated significantly lower interleukln-6 levels com- 
pared with their sedentwy controls (1 O*O.Z vs. 1.6kO.2 pg/mL). 
Conclusions: Physically active post-menopausal women exhibited lower plasma CRP 
levels than sedentary controls. Importantly, the HRT-related elevation in plasma CRP 
concentrations observed in sedentay women was absent in physically active women. 
These data suggest that habitual physical activity may prevent the adverse effect of HRT 
use on CRP concentrations, potenbally reducing the associated cardiovascular risk in 
postmenopausal women. 
9:45 a.m. 
840-6 Association Between Soluble CD40L and Asymptomatic 
Carotid Plaque 
Salvatore Now, Stefania Basill, Rosalba Tantillo, Angela Falco, Valentina Davi’, 
Giuseppina Now Batbagallo Carlo, Giovanni Davi’. University “G. D’Annunz~o”, Chieti, 
Italy, University of Palermo, Palermo, Italy 
Background Inflammation is a key feature of the development of atherosclerotic plaque. 
CD40 ligand (CD40L). mediates several processes in atherogenesis and it can be 
released from the platelets upon their activation. Plasma levels of CD40L may predict 
patlents with features suggestw of high-risk plaque (Eur Heal J 2002,4:292). 
Methods: We tested the hypothesis that plasma levels of CD4OL in asymptomatic 
carotid plaque may predict risk of cardiovascular (Q/D) events prospectively. We 
enrolled 42 outpatients (26 men, 16 women; mean age, 64210 years) with asymptomatic 
carotid stenoses greater than 15% in either internal or common carotid artery by carotid 
ultrasonography. As control group, we selected 21 subjects wthout any carotid stenosis 
matched for age, sex and smoking habit. All subjects had at least a major cardiovascular 
risk factor (CRF). Plasma levels of CRP, IL-6. TGF-betal, and sCD40L were measured 
by ELISA. Subjects undergo follow-up examinations every 12 months, or when they 
experienced a clinical CVD event. Planned duration of follow-up was in median 8 years. 
Myocardial Infarction, angina, stroke, transient ischemic attack, carotid endarterectomy, 
and intermittent claudication were considered as CVD events at follow up. 
Results Patients with asymptomatIc low-grade carotid stenws had significantly higher 
levels of CRP (p<O.OOOl), IL6 (p<O.OOOl), TGF-beta1 (p<O.OOOl) and sCD46L 
(pcO.0001) than controls. Soluble CD40 Ligand showed a significant correlation with 
CRP (Rhoz0.59, PcO.0001). A subgroup analysis of soluble CD40 ligand distribution 
showed that its plasma levels were still higher in patients compared to controls irrespec- 
tively of any CRF. No patient was lost to follow-up. Durmg follow-up, 14 (33%) patients 
experienced a CVD event. Forward stepwise Cox regression was used 10 search for the 
relevance of inflammatory variables for the prediction of these events. Only high CD40L 
levels [Hazard Ratio: 5.96; 95% confidence interval, 1.133 to 19.42, p=OO3] independently 
predict the risk of CVD events. 
Conclusions: High levels of CD40L may predict risk of CVD events prospectively m 
patients wth asymptomatic carotid plaque. 
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1152-i 20 Downregulation of Insulin-Like Growth Factor-l 
Receptor in Atherosclerotic Plaque: Role of Oxidized 
Low-Density Lipoprotein and PPARy 
Tao Peng Jie Du, Koichi One. Hiroyuki Itabe, Yusuke Higashi, Arkady Goubine, Patrice 
Delafontaine, The University of Kansas Medical Center, Kansas City, KS 
OxLDL has multiple proatherogenic effects including promotion of apoptosis. We have 
recently shown that OxLDL markedly downregulates Insulin-like growth factor-l (IGF-1) 
and IGF-1 Receptor (IGF-iR) in vascular smooth muscle cells (VSMC) providing a 
potential mechanism for OxLDL pro-apoptotic effects. To determine mechanisms of 
OxLDL regulation of IGF-1 R we exposed human VSMC to O-100 ug/ml OxLDL or native 
LDL (nLDL) and measured IGF-1R expression by western blotting. While 100 “g/ml 
nLDL upregulated IGF-1R expression (39%, n=5, p<.O5), OxLDL dose dependently 
downregulated IGF-1 R (61% reduction with 100 @ml, n=5, pcO.05) and induced VSMC 
apoptosis as detected by DNA fragmentation and increased caspase-3 activity. OxLDL 
triggers multiple signaling pathways including ~38 MAPK and PPARy pathways. To eluci- 
date mechanisms of OxLDL downregulation of IGF-1R we inhibited ~38 MAPK using 10 
uM 58203580 and blunted OxLDL downregulation of IGF-1 R by 53% (n=3, ~~0.05). This 
was confirmed by infection of VSMC with adenoviruses overexpressmg dominant nega- 
tive ~38 MAPK or its upstream klnase MKKB. PPARy IS expressed in atherosclerotic 
plaque. To &sess its potential mvolvement in OxLDL effects on IGF-1R we exposed 
VSMC lo O-100 us/ml OxLDL with or without the PPARy inhibitor PGFP n, 200 nM. 
Although PGF2 a did not block OxLDL downregulation of the IGF-1R. surprisingly 
PPARy inhibition upregulated basal IGF-1R levels (340% increase, n=5). Furthermore, 
the synthetic PPARy ligand, ciglltazone 10 uM, downregulated IGF-1R levels (50% 
decrease, n=4, p<O.O5). Inhibition of scavenger receptor A and B using 40 nM fucoidin or 
anti-CD36 antibody respectively. did not block OxLDL downregulation of IGF-1 R. In con- 
clusion: 
1. OxLDL downregulates IGF-1 R wa a ~38 MAPK dependent, PPARy independent path- 
way not involving the classical scavenger receptors A and B. 
2. PPARy activation downregulates IGF-1 R in VSMC, providmg a new target for PPARy 
effects on the vasculature. These findings provide lmporlant irwghts into mechanisms 
whereby OxLDL triggers apoptosis of VSMC and provide a new paradigm for the 
potential role of PPARyin atherosclerosis. 
